Future Health ESG Operating Margin 2022-2023 | FHLT
Current and historical operating margin for Future Health ESG (FHLT) over the last 10 years. The current operating profit margin for Future Health ESG as of December 31, 2023 is 0.00%.
| Future Health ESG Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.071B | $0.000B |
| Future Health ESG Corp. entered into a definitive business combination agreement with Excelera DCE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.275B | 19.92 |
| Inspire Medical Systems (INSP) | United States | $7.566B | 0.00 |
| Axonics (AXNX) | United States | $3.433B | 0.00 |
| 10x Genomics (TXG) | United States | $3.275B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.194B | 0.00 |
| Azenta (AZTA) | United States | $2.979B | 242.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.861B | 0.00 |
| Enovis (ENOV) | United States | $2.812B | 20.84 |
| Hims & Hers Health (HIMS) | United States | $2.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.224B | 98.63 |
| Schrodinger (SDGR) | United States | $1.712B | 0.00 |
| Omnicell (OMCL) | United States | $1.384B | 47.83 |
| Phreesia (PHR) | United States | $1.259B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.828B | 0.00 |
| Standard BioTools (LAB) | United States | $0.728B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.383B | 0.00 |
| Pulmonx (LUNG) | United States | $0.378B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.344B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| Outset Medical (OM) | United States | $0.162B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.125B | 0.00 |
| TruBridge (TBRG) | United States | $0.125B | 5.33 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.108B | 0.00 |
| 111 (YI) | China | $0.096B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.046B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |